MedTrace Logo

Photobiomodulation Therapy for Pain Control in Post-Operative Total Knee Arthroplasty Patients: A Pilot Study

NCT07750912 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-08-06

No results posted yet for this study

Summary

A pilot study to assess the efficacy and feasibility of PBMT for pain control in patients undergoing a TKA and are discharged the same day from an ambulatory surgery center.

Conditions

  • Pain Management
  • TKA
  • Post Operative Analgesia
  • Low Level Laser Therapy

Interventions

DEVICE

LightForce XLI

The LightForce XLi laser is FDA cleared to emit energy in the visible and near infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for a temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain, or muscle spasm; the temporary increase in local blood circulation; and the temporary relaxation of muscle. The specific use of this device to decrease post-operative pain and improve function may be considered an off-label use. However, it is important to note that the off-label use of this device in the context of this study does not alter the fundamental safety or performance profile of the device in participants. This device (and other substantially equivalent devices) is commonly used in clinical practice in a rehabilitation setting to treat post-operative conditions and several studies have demonstrated safety and efficacy in post-operative use.

Sponsors & Collaborators

  • Enovis

    collaborator INDUSTRY

  • Mohammad Burney, MD

    lead OTHER

Principal Investigators

  • Mohammed U Burney, MD · North Texas Medical Research Institute, PLLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-07-31
Completion
2028-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07750912 on ClinicalTrials.gov